Denali Therapeutics
Logotype for Denali Therapeutics Inc

Denali Therapeutics (DNLI) investor relations material

Denali Therapeutics Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Denali Therapeutics Inc
Q4 2025 earnings summary26 Feb, 2026

Executive summary

  • Commercial launch readiness for tividenofusp alfa (DNL310) established ahead of April 2026 FDA decision for Hunter syndrome.

  • Preliminary Phase 1/2 data for DNL126 in Sanfilippo syndrome type A support accelerated approval plans; global Phase 3 study in planning.

  • Start-up activities underway for DNL628 (Alzheimer's) and DNL952 (Pompe disease) Phase 1 studies.

  • Multiple programs advancing in lysosomal storage disorders and neurodegenerative diseases.

  • $275M synthetic royalty funding and $200M public offering completed in December 2025.

Financial highlights

  • Net loss was $128.5M for Q4 2025 and $512.5M for FY 2025, compared to $114.8M and $422.8M in 2024.

  • R&D expenses were $97.9M for Q4 and $418.8M for FY 2025, up $22.4M year-over-year due to higher external costs and manufacturing expansion.

  • General and administrative expenses rose to $39.5M for Q4 and $136.6M for FY 2025, driven by headcount and launch preparation.

  • Cash, cash equivalents, and marketable securities totaled $966.2M as of December 31, 2025.

Outlook and guidance

  • Anticipated FDA decision and commercial launch for tividenofusp alfa in April 2026.

  • Initial patient data for TAK-594/DNL593 (FTD-GRN) and Phase 2b LUMA study (Parkinson's) expected in 2026.

  • Four to six additional programs expected to enter the clinic over the next three years.

DNL310 launch prep: key commercial steps?
Strategy for 4-6 new clinical programs?
R&D spend shift: small molecule to TV programs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Denali Therapeutics earnings date

Logotype for Denali Therapeutics Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026
Denali Therapeutics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Denali Therapeutics earnings date

Logotype for Denali Therapeutics Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company researches and creates treatments targeting conditions such as Alzheimer's disease, Parkinson’s disease, and other disorders affecting the central nervous system. Denali Therapeutics operates within the healthcare and biotechnology sectors. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage